Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2022
IDT Biologika and Exothera collaborate on viral vaccine manufacturing
IDT Biologika and Exothera announced a collaboration to develop a large-scale manufacturing process for viral vector-based vaccines, using Modified Vaccinia Ankara virus as the first example in a feasibility study.
2021
AstraZeneca and IDT Biologika form vaccine manufacturing partnership
AstraZeneca and IDT Biologika formed a manufacturing partnership to increase production of AstraZeneca's COVID-19 vaccine in the EU. They intend to jointly invest in additional drug-substance capacity and plan investments at IDT's Dessau site.